Kintara Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BELL JOHN K director
Common Stock 8,000 $0.95 $7,600
Purchase
BACHA JEFFREY director
Common Stock 4,000 $0.98 $3,920
Purchase
BACHA JEFFREY director
Common Stock 4,985 $0.75 $3,739
Purchase
BELL JOHN K director
Common Stock 7,000 $0.71 $4,970
Purchase
BELL JOHN K director
Common Stock 8,000 $0.78 $6,240
Purchase
BELL JOHN K director
Common Stock 20,000 $1.25 $25,000
Purchase
PRAILL SCOTT
Common Stock 10,000 $1.3 $13,000
Sale
GARNER WILLIAM J director
Common Stock 80,000 $1.3 $104,000
Purchase
BROWN DENNIS M officer: Chief Scientific Officer
Common Stock 10,000 $1.3 $13,000
Purchase
BACHA JEFFREY director
Common Stock 10,000 $1.3 $13,000
Purchase
BELL JOHN K director
Common Stock 25,000 $1.3 $32,500
Purchase
TOTH ROBERT JOSEPH JR director
Common Stock 25,000 $1.3 $32,500
Purchase
BROWN DENNIS M officer: Chief Scientific Officer
Common Stock 5,000 $1.56 $7,810
Purchase
BACHA JEFFREY director
COMMON STOCK 5,000 $1 $5,000
Purchase
BACHA JEFFREY director
COMMON STOCK 5,000 $0.8 $4,000
Purchase
BELL JOHN K director
Common Stock 9,000 $0.83 $7,506
Purchase
TOTH ROBERT JOSEPH JR director
COMMON STOCK 9,000 $0.88 $7,920
Purchase
TOTH ROBERT JOSEPH JR director
Common Stock 2,000 $0.87 $1,740
Purchase
TOTH ROBERT JOSEPH JR director
COMMON STOCK 7,500 $0.91 $6,825
Purchase
GARNER WILLIAM J director
Common Stock 5,000 $1 $5,000

Showing 50 to 70 of 70 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.